Items where authors include "Marchi, P.M."

Article

Wiseman, J.P., Scarrott, J.M. orcid.org/0000-0002-6046-7687, Alves-Cruzeiro, J. et al. (21 more authors) (2024) Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. EMBO Molecular Medicine, 16 (11). pp. 2882-2917. ISSN 1757-4676

Scarrott, J.M. orcid.org/0000-0002-6046-7687, Alves-Cruzeiro, J., Marchi, P.M. et al. (7 more authors) (2023) Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization. Brain Communications, 5 (1). fcac335.

Marchi, P.M. orcid.org/0000-0002-8893-3790, Marrone, L., Brasseur, L. et al. (19 more authors) (2022) C9ORF72-derived poly-GA DPRs undergo endocytic uptake in iAstrocytes and spread to motor neurons. Life Science Alliance, 5 (9). e202101276. ISSN 2575-1077

Marrone, L., Marchi, P.M. orcid.org/0000-0002-8893-3790, Webster, C.P. orcid.org/0000-0003-4197-2036 et al. (11 more authors) (2022) SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction. Human Molecular Genetics, 31 (16). pp. 2693-2710. ISSN 0964-6906

Karyka, E., Berrueta Ramirez, N., Webster, C.P. orcid.org/0000-0003-4197-2036 et al. (11 more authors) (2022) SMN-deficient cells exhibit increased ribosomal DNA damage. Life Science Alliance, 5 (8). e202101145. ISSN 2575-1077

Marrone, L., Marchi, P.M. orcid.org/0000-0002-8893-3790 and Azzouz, M. orcid.org/0000-0001-6564-5967 (2022) Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. Expert Opinion on Biological Therapy, 22 (9). pp. 1163-1176. ISSN 1471-2598